We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+0.12%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$306B
AUM Growth
+$4.93B
Cap. Flow
+$7.83B
Cap. Flow %
2.56%
Top 10 Hldgs %
17.03%
Holding
3,610
New
202
Increased
2,185
Reduced
922
Closed
109

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$269M
2
AMZN icon
Amazon
AMZN
+$242M
3
AAPL icon
Apple
AAPL
+$215M
4
AMGN icon
Amgen
AMGN
+$212M
5
CFG icon
Citizens Financial Group
CFG
+$193M

Sector Composition

Rank Sector Weight
1 Technology 20.58%
2 Financials 13.47%
3 Healthcare 12.09%
4 Consumer Discretionary 10.78%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZEV
3376
DELISTED
Lightning eMotors, Inc.
ZEV
$104K ﹤0.01%
602
CFMS
3377
DELISTED
Conformis, Inc. Common Stock
CFMS
$103K ﹤0.01%
3,085
MTNB icon
3378
Matinas BioPharma
MTNB
$1.68M
$102K ﹤0.01%
1,568
CALA
3379
DELISTED
Calithera Biosciences, Inc
CALA
$102K ﹤0.01%
2,318
+1,148
+98% +$49.5K
QCLS
3380
Q/C Technologies Inc
QCLS
$22.7M
$101K ﹤0.01%
5
PVLA
3381
Palvella Therapeutics
PVLA
$2.22B
$101K ﹤0.01%
243
OKUR
3382
OnKure Therapeutics
OKUR
$166M
$100K ﹤0.01%
1,337
MKTW icon
3383
MarketWise
MKTW
$52.8M
$97K ﹤0.01%
+585
New +$114K
HPK icon
3384
HighPeak Energy
HPK
$1.04B
$96K ﹤0.01%
10,561
XELA
3385
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$95K ﹤0.01%
+12
New +$123K
NH
3386
DELISTED
NantHealth, Inc
NH
$94K ﹤0.01%
3,871
-1,028
-21% -$30.9K
TFFP
3387
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$93K ﹤0.01%
+479
New +$102K
VTNR
3388
DELISTED
Vertex Energy, Inc
VTNR
$93K ﹤0.01%
17,703
+7,408
+72% +$58.8K
IMMR icon
3389
Immersion
IMMR
$248M
$90K ﹤0.01%
+13,101
New +$97.8K
SUNL
3390
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
$90K ﹤0.01%
+839
New +$119K
UTI icon
3391
Universal Technical Institute
UTI
$1.4B
$89K ﹤0.01%
13,059
ADMS
3392
DELISTED
Adamas Pharmaceuticals
ADMS
$88K ﹤0.01%
17,873
UONEK icon
3393
Urban One Class D
UONEK
$23.7M
$86K ﹤0.01%
+1,250
New +$72.2K
ATIP
3394
DELISTED
ATI Physical Therapy, Inc.
ATIP
$85K ﹤0.01%
+443
New +$113K
FBRX icon
3395
Forte Biosciences
FBRX
$1.58B
$84K ﹤0.01%
1,135
+35
+3% +$19.4K
RVSB icon
3396
Riverview Bancorp
RVSB
$107M
$84K ﹤0.01%
11,437
TREC
3397
DELISTED
Trecora Resources
TREC
$84K ﹤0.01%
10,224
GNLN icon
3398
Greenlane Holdings
GNLN
$1.24M
0
MFIN icon
3399
Medallion Financial
MFIN
$253M
$83K ﹤0.01%
10,486
TUEM
3400
DELISTED
Tuesday Morning Corp
TUEM
$82K ﹤0.01%
+971
New +$106K

Similar funds

Charles Schwab's Q3 2021 Portfolio in Review

As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
  • Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
  • Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
  • Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
  • Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
  • Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
  • Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.

Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.